artenimol has been researched along with Cancer of Gallbladder in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gong, W; Hu, Y; Jiang, L; Li, H; Liang, H; Liu, Y; Ma, Q; Wang, X; Wang, Z; Xiang, S; Xu, Z; Ye, Y; Zhang, F; Zhang, Y | 1 |
1 other study(ies) available for artenimol and Cancer of Gallbladder
Article | Year |
---|---|
Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer.
Topics: Animals; Antineoplastic Agents; Artemisinins; Biomarkers, Tumor; cdc42 GTP-Binding Protein; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Female; Gallbladder Neoplasms; Heterografts; Humans; Mice; Neoplasm Metastasis; Neoplasm Staging; Tumor Protein, Translationally-Controlled 1 | 2017 |